
business
AstraZeneca Announces Higher Q2 Net Profit Due to Robust Cancer Drug Sales
AstraZeneca's net profit increased by over two percent to $2.5 billion in Q2 2026, driven by strong sales in cancer and rare disease medicines.
Topic
Latest news and analysis on “Pascal Soriot”.

AstraZeneca's net profit increased by over two percent to $2.5 billion in Q2 2026, driven by strong sales in cancer and rare disease medicines.